|
|
Volumn 15 Suppl 5, Issue , 2010, Pages 18-28
|
|
New developments in hormone receptor-positive disease.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
CYTOCHROME P450 2D6;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
HER2 PROTEIN, HUMAN;
KI 67 ANTIGEN;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL (TOPIC);
FEMALE;
GENE EXPRESSION PROFILING;
HUMAN;
METABOLISM;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
CYTOCHROME P-450 CYP2D6;
FEMALE;
GENE EXPRESSION PROFILING;
HUMANS;
KI-67 ANTIGEN;
NEOPLASM STAGING;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RECEPTORS, PROGESTERONE;
TAMOXIFEN;
TREATMENT OUTCOME;
|
|
EID: 79952663260
PISSN: None
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2010-S5-18 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
